| |
| |
|
| Insider
Information: |
Culpepper Peter R |
| Relationship: |
Interim CEO, CFO, COO |
| City: |
Oak Rige |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,411,829 |
|
|
Indirect Shares
|
296,503 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,708,332 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Provectus Biopharmaceuticals Inc |
PVCT |
Interim CEO, CFO, COO |
2016-03-29 |
1,411,829 |
2016-03-29 |
296,503 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PVCT |
Provectus Biopharmaceutic... |
Interim CEO, CFO, COO |
• – – |
2016-03-29 |
4 |
A |
$1.00 |
$106,000 |
I/I |
106,000 |
296,503 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Interim CEO, CFO, COO |
• – – |
2016-03-29 |
4 |
A |
$1.00 |
$160,666 |
D/D |
160,666 |
1,411,829 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO & COO |
• – – |
2015-12-09 |
4 |
OE |
$0.94 |
$6,000 |
I/I |
6,383 |
190,503 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO & COO |
• – – |
2015-12-09 |
4 |
OE |
$0.94 |
$130,501 |
D/D |
138,831 |
1,251,163 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO & COO |
• – – |
2015-01-07 |
4 |
OE |
$0.75 |
$52,999 |
I/I |
63,120 |
184,120 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO & COO |
• – – |
2014-06-28 |
4 |
OE |
$1.25 |
$125,000 |
D/D |
100,000 |
1,112,332 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO & COO |
• – – |
2014-02-26 |
4 |
OE |
$1.10 |
$133,100 |
I/I |
121,000 |
121,000 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO & COO |
• – – |
2014-02-26 |
4 |
OE |
$1.10 |
$75,486 |
D/D |
68,624 |
1,012,332 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO, COO |
• – – |
2012-12-03 |
4 |
B |
$0.00 |
$0 |
D/D |
133,333 |
943,708 |
2.66 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
CFO, COO |
• – – |
2012-11-16 |
4 |
B |
$0.00 |
$0 |
D/D |
133,333 |
810,375 |
2.66 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2011-05-03 |
4 |
OE |
$0.75 |
$100,000 |
D/D |
133,333 |
677,042 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2010-12-29 |
4 |
OE |
$0.75 |
$100,000 |
D/D |
133,333 |
543,709 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2009-06-11 |
4 |
OE |
$0.64 |
$96,000 |
D/D |
150,000 |
410,376 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2008-06-12 |
4/A |
OE |
$1.10 |
$49,275 |
D/D |
44,795 |
260,376 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2008-06-12 |
4 |
OE |
$1.10 |
$49,275 |
D/D |
44,795 |
110,376 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2007-11-12 |
4 |
OE |
$0.64 |
$32,000 |
D/D |
50,000 |
215,581 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2007-09-13 |
4 |
OE |
$0.64 |
$16,000 |
D/D |
25,000 |
165,581 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2007-08-23 |
4 |
OE |
$0.64 |
$48,000 |
D/D |
75,000 |
140,581 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-11-30 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
65,581 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-10-30 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
62,081 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-09-28 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
58,581 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-08-30 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
55,081 |
|
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-07-30 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
51,581 |
|
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-07-05 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
48,081 |
0 |
- |
|
| PVCT |
Provectus Biopharmaceutic... |
Chief Financial Officer |
• – – |
2006-05-30 |
4 |
OE |
$1.10 |
$3,850 |
D/D |
3,500 |
44,581 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
